Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5614856 | Journal of Cardiology | 2016 | 6 Pages |
Abstract
Results from this subgroup analysis, particularly the fact that there was no repeated or sequential pattern between NMCRB and MB occurrences in both treatment groups, suggests that NMCRB might not be a predictive factor for MB. On the contrary, anemia and concomitant use of antiplatelet therapy were likely predictive factors for bleeding with warfarin and rivaroxaban treatment, respectively.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Masatsugu MD, PhD, FJCC, Masayasu MD, PhD, Norio MD, Shin-ichi MD, FJCC, Shinichiro MD, PhD, Shinya MD, PhD, FJCC, Tohru MD, PhD, FJCC, Yukihiro MD, PhD, FJCC, Mariko MD, PhD, Masaharu MSc, Mary MD, Kazuma MD, PhD, Satoshi MD, PhD,